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Introduction
Testicular germ-cell cancer (TGCC) is the most common
cancer of young Caucasian men with a peak incidence
occurring at around 25–30 years (Skakkebaek et al.,
2001). In most Western countries, TGCC has increased
progressively in incidence over the last 40–70 years, indic-
ative of lifestyle⁄environmental causes (Bray et al., 2006).
It is widely accepted that TGCC develops from pre-malig-
nant carcinoma-in-situ (CIS) cells, which in turn result
from foetal germ cells (GCs) that have failed to undergo
normal differentiation in foetal⁄early postnatal life and
have failed to switch off pluripotency characteristics
(Rajpert-De Meyts, 2006; Van Casteren et al., 2009). If
CIS cells are identiﬁed in a testis, it predicts that TGCC
will eventually develop (Skakkebaek et al., 2001). Two
major unresolved issues about CIS are: (1) why does
differentiation fail in some foetal GC, and (2) what
lifestyle⁄environmental factors can inﬂuence this, and
thus explain the progressive increase in TGCC incidence.
TGCC is hypothesized to form part of a testicular dys-
genesis syndrome (TDS), because of its foetal origins and
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Summary
Environmental factors are implicated in increased incidence of human testi-
cular germ-cell cancer (TGCC). TGCC has foetal origins and may be one
component of a testicular dysgenesis syndrome (TDS). Certain phthalates
induce TDS in rats, including effects on foetal germ cells (GC). As humans are
widely exposed to phthalates, study of the effects of phthalates on foetal rat GC
could provide an insight into the vulnerability of foetal GC to disruption by
environmental factors, and thus to origins of TGCC. This study has therefore
characterized foetal GC development in rats after in utero exposure to
di(n-butyl) phthalate (DBP) with emphasis on GC numbers⁄proliferation,
differentiation and time course for inducing effects. Pregnant rats were treated
orally from embryonic day 13.5 (e13.5) with 500 mg⁄kg⁄day DBP for varying
periods. GC number, proliferation, apoptosis, differentiation (loss of OCT4,
DMRT1 expression, DMRT1 re-expression, GC migration) and aggregation
were evaluated at various foetal and postnatal ages. DBP exposure reduced foe-
tal GC number by 60% by e15.5 and prolonged GC proliferation, OCT4 and
DMRT1 immunoexpression; these effects were induced in the period immedi-
ately after testis differentiation (e13.5–e15.5). In contrast, DBP-induced GC
aggregation stemmed from late gestation effects (beyond e19.5). Foetal DBP
exposure delayed postnatal resumption of GC proliferation, leading to bigger
deﬁcits in numbers, and delayed re-expression of DMRT1 and radial GC
migration. Therefore, DBP differentially affects foetal GC in rats according to
stage of gestation, effects that may be relevant to the human because of their
nature (OCT4, DMRT1 effects) or because similar effects are demonstrable in
vitro on human foetal testes (GC number). Identiﬁcation of the mechanisms
underlying these effects could give a new insight into environment-sensitive
mechanisms in early foetal GC development that could potentially be relevant
to TGCC origins.
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tion⁄reproductive developmental disorders (Skakkebaek
et al., 2001; Sharpe & Skakkebaek, 2008). An animal
model for TDS, involving administration of certain phth-
alate esters, such as di(n-butyl) phthalate (DBP), to
female rats during pregnancy has been established and
results in a spectrum of disorders similar to TDS in
humans (Gray et al., 2000; Barlow & Foster, 2003; Fisher
et al., 2003), and some evidence points towards similar
phthalate effects in humans (Swan et al., 2005). Foetal
exposure of rats to DBP, or to other phthalates that can
induce a TDS-like syndrome, causes major effects on the
foetal GC, including a reduction in numbers plus multi-
nucleation and abnormal aggregation (Mylchreest et al.,
2000; Mylchreest et al., 2002; Parks et al., 2000; Fisher
et al., 2003; Ferrara et al., 2006; Boekelheide et al., 2009).
Moreover, some of these phthalate effects have been reca-
pitulated in vitro using foetal testis explants from the rat
(Chauvigne ´ et al., 2009), mouse (Lehraiki et al., 2009)
and human (Lambrot et al., 2009), demonstrating the
potential relevance of the animal studies to the human.
Humans are widely exposed to phthalates (Silva et al.,
2004a), notably to DBP and diethylhexyl phthalate
(DEHP), both of which cause similar effects on the foetal
rat testis (Howdeshell et al., 2008a). DBP⁄DEHP exposure
of rats does not lead to formation of recognizable CIS
cells or to development of TGCC in adulthood, but an
earlier study showed that foetal exposure of rats to DBP
resulted in delayed ‘differentiation’ of some foetal gono-
cytes (Ferrara et al., 2006), an effect potentially relevant
to CIS origins (Rajpert-De Meyts, 2006). From the evi-
dence available, it is unclear if this ‘differentiation effect’
is unique and⁄or whether it is related to the other GC
effects described. The objective of the present studies was
to characterize the GC effects of DBP in rats, especially
those relating to their numbers and differentiation, to
identify the timing of phthalate-sensitive periods in foetal
GC development, as these could lead to identiﬁcation of
early foetal GC mechanisms that are vulnerable to disrup-
tion by environmental factors, which might then shed
light on CIS origins.
Materials and methods
Animal welfare, treatments, sample collection and
processing
Wistar rats were maintained under United Kingdom Home
Ofﬁce guidelines in our own animal facility and fed a soy-
free breeding diet (SDS, Dundee, Scotland). Experiments
were conducted under Project Licence approval from the
UK Home Ofﬁce, which includes an ethical review step.
Time-mated females were subjected to daily oral gavage
with either 500 mg⁄kg DBP (Sigma-Aldrich Co. Ltd.,
Dorset, UK) in 1 mL⁄kg corn oil or with the vehicle
(control); the DBP was 99% pure according to the sup-
plier. For the main experiments involving foetal recovery
of tissues (e14.4–e21.5), treatments were administered
daily until 24 h before the dam was killed; where recovery
of tissues was postnatal, dams were treated daily from
e13.5 to e21.5. In some studies, DBP or vehicle was
administered from e13.5 to e15.5 (termed ‘early window’)
and exposed animals subsequently killed on e17.5, e19.5
or e21.5. Similarly, in one experiment, DBP⁄vehicle treat-
ment was conﬁned to e19.5–e20.5 (‘late window’) and
control and treated animals were then killed on e21.5.
In all studies, at least four foetuses from a minimum of 3–5
separate litters were used for the studies described next.
The dose of DBP used for the present studies induces a
high incidence of TDS-like disorders and acute and long-
term effects on GC development in Wistar rats (Fisher
et al., 2003; Ferrara et al., 2006). Animals exposed to DBP
in foetal life were killed at various foetal (e14.5, e15.5,
e17.5, e19.5, e21.5) or postnatal (postnatal days 6, 8, 10,
15) ages depending on the experiment. To collect foetus-
es, dams were killed by CO2 inhalation followed by cervi-
cal dislocation, the foetuses removed, decapitated and
stored in ice-cold phosphate-buffered saline (Sigma-
Aldrich) prior to microdissection of testes. Postnatal
animals under the age of Pnd10 were decapitated and
animals over Pnd10 killed by CO2 inhalation followed by
cervical dislocation prior to testes removal. Testes were
either frozen ()80  C) for RNA analysis or ﬁxed for
30–360 min in Bouin’s ﬁxative, depending on age, before
being transferred to 70% ethanol. Fixed tissue was
processed into parafﬁn wax blocks using an automated
processor.
In animals used to determine the GC proliferation
index (PI), 100 mg⁄kg bromo-2¢-deoxyuridine-5¢-mono-
phosphate (BrdU; Sigma) was administered in 2 mL⁄kg
saline via intraperitoneal injection to either the pregnant
dam (for foetal animals) or directly to the males (post-
natal animals) 1.5 h prior to death.
Immunohistochemical analysis of GC development
Immunohistochemistry was used to identify GCs for enu-
meration (DAZL (deleted in azoospermia) and VASA) or
aggregation (VASA), or to evaluate the progress of GC dif-
ferentiation [OCT4 (octamer-binding transcription factor
3⁄4; also termed POU5F1) and DMRT1 (Doublesex and
MAB-3-related transcription factor 1)], or to determine
the PI using BrdU as a proliferation marker, or to deter-
mine GC location within the seminiferous tubules of post-
natal animals [smooth muscle actin (SMA) used to label
peritubular cells adjacent to the basement membrane].
These speciﬁc proteins were detected using speciﬁc anti-
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ods described and validated elsewhere (Raymond et al.,
2000; Fisher et al., 2003; Hutchison et al., 2008). Some
antibodies required antigen retrieval for optimal detection
(Table 1), by pressure cooking slides for 5 min in 0.01m
citrate buffer (pH 6.0). Serum blocking to prevent non-
speciﬁc background staining used the appropriate normal
serum diluted 1 : 5 in Tris-buffered saline (TBS) with 5%
bovine serum albumin (Sigma). Slides were incubated
overnight with primary antibody (Table 1) at 4  C and
detected using the appropriate secondary antibody conju-
gated to biotin at 1 : 500 in TBS for 30 min at room tem-
perature. The biotinylated secondary was linked to
horseradish peroxidase by 30 min incubation with strepta-
vidin-horseradish peroxide enzyme conjugate (Vector
Labs, Peterborough, UK) and visualized by application of
diaminobenzidine (liquid DAB; Dako, Glostrup, Den-
mark). Slides were counterstained with haematoxylin,
dehydrated and mounted using Pertex mounting medium
(Cell Path, Hemel Hampstead, UK).
To determine the GC PI or the percentage of GCs
expressing OCT4 or DMRT1, or to determine the posi-
tion of GCs within the seminiferous cords, double immu-
nohistochemistry was used, essentially as described
elsewhere (Fisher et al., 2003). For this, slides underwent
second antibody detection for a different antigen after the
initial antibody detection. Brieﬂy, after DAB application
and TBS washing, slides underwent a second 30-min
serum block appropriate to the second primary antibody
(Table 1) and the above process was then repeated. To
detect the second primary antibody, slides were incubated
with the appropriate secondary antibody conjugated to
alkaline phosphatase (Dako; 1 : 200) for 30 min at room
temperature with visualization using Fast Blue [1 mg Fast
Blue salt (Sigma) in 1 mL Fast Blue buffer (12.1 mg Tris,
0.2 mg napthol AS-MX phosphate, 20 lL dimethyl form-
amide, pH 8.2)]. Slides were then mounted using Perma-
ﬂuor aqueous mounting ﬂuid (Beckham Coulter, High
Wycombe, UK). Apoptosis of GCs in complete testis
cross-sections at each age, was assessed using TUNEL
(terminal deoxynucleotidyl transferase dUTP nick end
labelling), as detailed previously (Atanassova et al., 2000).
Slides were viewed using a Provis microscope (Olympus
Optical AX70, London, UK) and images were captured
using a DCS330 digital camera (Eastman Kodak, NY,
USA).
Determination of GC number per testis
GC number per testis was evaluated using DAZL-immuno-
stained slides (Fisher et al., 2003) and stereological meth-
ods described previously (Scott et al., 2008; Hutchison
et al., 2008). This used Image-Pro 6.2 software (Media
Cybernetics UK, Wokingham, Berkshire, UK) and an
Olympus BH-2 microscope ﬁtted with a Prior automatic
stage (Prior Scientiﬁc Instruments Ltd., Cambridge, UK).
The number of ﬁelds counted per animal was dependent
on obtaining a standard error value of £5%. Conversion of
volume data to cell numbers per testis used the mean
nuclear volume of GCs at that age (average of 80–100
nuclei) using the selector function of the software and testis
volume (see next). GCs were counted at e14.5, e15.5, e17.5,
e19.5, e21.5, Pnd6 and Pnd15 in control and DBP-exposed
animals (n = 5–8 per group).
Testes from postnatal animals and foetuses aged over
e19.5 were weighed directly, but in younger animals, total
testis volume was determined by reconstruction from
serial sectioning combined with measurements made on
photographic images of microdissected gonads as
described previously (Scott et al., 2007). Although we
have validated this approach (Scott et al., 2007), use of
different methods for volume determination at different
ages will have introduced different errors, which may also
vary according to age. Therefore, we do not consider that
comparison of GC numbers at different foetal ages is
accurate, whereas any comparison of control and DBP-
exposed animals at the same age will be subject to the
same errors and are thus comparable.
Analysis of GC proliferation, differentiation and migra-
tion within the seminiferous cords
Two key protein markers were used to evaluate DBP
effects on GC differentiation. OCT4 is a pluripotency-
associated factor and is the classic marker of CIS⁄TGCC
cells in the human (Rajpert-De Meyts, 2006) and its
expression can be altered by foetal DBP exposure (Ferrara
et al., 2006). DMRT1 was chosen because (i) it plays a
highly conserved role in sexual differentiation (Zarkower,
2001); (ii) it is expressed in foetal GCs and Sertoli cells;
(iii) its knockout in mice results in abnormal GC devel-
opment (Raymond et al., 2000; Kim et al., 2007); (iv)
DMRT1 is associated with maintenance of pluripotency
and can regulate a number of pluripotency-associated
Table 1 Details of primary antisera used for immunohistochemistry
Antibody Source Retrieval Species Dilution
BrdU Fitzgerald Industries, MA Yes Sheep 1 : 1000
DAZL AbD Serotec, Oxford Yes Mouse 1 : 300
DMRT1 Gift from David Zarkower Yes Rabbit 1 : 2000
OCT4 Santa Cruz, CA, USA Yes Goat 1 : 100
SMA Novocastra, Newcastle No Mouse 1 : 1000
VASA Abcam, Cambridge Yes Rabbit 1 : 200
BrdU, bromo-2¢-deoxyuridine-5¢-monophosphate; DMRT1, Doublesex
and MAB-3-related transcription factor 1; OCT4, octamer-binding
transcription factor 3⁄4; SMA, smooth muscle actin.
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2010).
To calculate the GC PI, or the percentage of GCs
expressing OCT4 or DMRT1, 30–50 random ﬁelds were
examined per testis and GCs were counted as positive or
negative for the marker in question (BrdU, OCT4 or
DMRT1). GC PI was determined at e15.5, e17.5, e19.5,
e21.5, Pnd6, Pnd8 and Pnd10. The percentage of OCT4-
expressing GCs was determined at e17.5, and the percent-
age of DMRT1-expressing GCs was determined at e19.5
and Pnd6. The reasons for choice of these ages are
explained in the ‘Results’ section.
At Pnd6, the position of GCs in seminiferous cords
was investigated using double immunohistochemistry for
the GC-speciﬁc marker VASA and for SMA (Fisher et al.,
2003) to identify peritubular myoid cells and the adjacent
basement membrane. GC position was classed as centrally
located or basally located, if some of the GC cytoplasm
was located at the basement membrane.
Measurement of GC aggregation at e21.5
DBP exposure causes aggregation of GCs in the foetal
testis beyond e19.5 (Fisher et al., 2003; Kleymenova et al.,
2005). As all GCs at e21.5 immunostain intensely for
VASA, we utilized this to develop a method for objective
quantiﬁcation of aggregation⁄clustering of GCs using a
similar approach to that described for quantiﬁcation
of foetal Leydig cell clustering (Mahood et al., 2005).
Sections immunostained for VASA were of sufﬁcient
contrast and low background to allow computer-assisted
thresholding and quantiﬁcation by stereological analysis
using Image-Pro Plus 4.5.1 with Stereologer-Pro 5
plug-in software (Media Cybernetics UK). Other details
are as in Mahood et al. (2005). In e21.5 controls, GC
clusters varied widely in size (<20–2800 arbitrary units)
although most were <1000 units. In DBP-exposed ani-
mals, there were fewer but larger GC clusters and 15%
of cords contained clusters >3000 units, a size rarely
found in controls. Various paradigms were explored for
discriminating control and DBP-exposed animals, but the
most robust was using clusters >3000 units as the cut-off
point. Therefore, the percentage of GCs in clusters >3000
units was used as an index of GC aggregation.
Oct4 mRNA expression in the foetal testis
To determine Oct4 mRNA expression levels in whole tes-
tes, standard Taqman Q-RT-PCR was used as described
elsewhere (Drake et al., 2009), with primers (forward:
GAAGTTGGAGAAGGTGGACC; reverse: CCTTCTGCA-
GGGCTTTCATA) and probe 95 from the Roche universal
probe library (http://www.roche-applied-science.com/sis/
rtpcr/upl/ezhome.html). Samples (n = 6 per age and
treatment) were analysed in triplicate (ABI 7900, Applied
Biosystems. Carlsbad, California, USA).
Statistical analysis
Data were analysed using Student’s unpaired t-test and
GraphPad Prism (version 5; GraphPad software Inc.,
San Diego, CA, USA). Some data were log-transformed
prior to statistical analysis to normalize variances.
In some instances, more than one animal was used per
litter; therefore, to rule out any statistically signiﬁcant
differences as stemming from between-litter, rather than
between-treatment, effects, data were also analysed using
litter means. This did not alter the results or conclusions,
although in some instances, it did reduce the level of
statistical signiﬁcance.
Results
Effect of DBP treatment on GC number
At all foetal (e14.5–e21.5) and postnatal (Pnd6, Pnd15)
ages investigated, GC number per testis was consistently
reduced in DBP-exposed animals, although this reduction
just failed to achieve statistical signiﬁcance at e19.5
(Fig. 1). The magnitude of the DBP-induced reduction
increased from e14.5 (29% reduction) to e15.5 (60%
reduction), but thereafter, somewhat lesser reductions
were found at e17.5 (48% reduction) and at e19.5–e21.5
(28–38%), perhaps reﬂecting some recovery of GC num-
bers because of prolongation of GC proliferation in DBP-
exposed animals (see next). In contrast, a much more
pronounced reduction in GC numbers was found postna-
tally (77% and 67% reductions at Pnd6 and Pnd15,
respectively; Fig. 1), a ﬁnding probably also explained by
altered GC proliferation on Pnd6 (see next). At face
value, our results in controls imply that GC number
increases beyond e17.5 when GC proliferation has ceased.
However, different methods were used for estimation of
testis volume up to e17.5 and thereafter, and this pre-
cludes accurate comparison of absolute GC numbers
between the different ages (see ‘Materials and methods’).
Effect of DBP treatment on GC proliferation and
apoptosis
To determine if increased apoptosis explained the reduc-
tion in GC number in DBP-exposed animals, complete
testis cross-sections were evaluated systematically, but
only occasional apoptotic GCs were observed at e14.5–
e17.5 (4–6 per complete testis cross-section) and none at
e19.5–e21.5. There was no consistent difference between
control and DBP-exposed groups in the numbers of
M. S. Jobling et al. DBP effects on foetal germ cells
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from animals 8 h after initial dosing of DBP on e13.5,
but at this age, seminiferous cord formation was only
initiating and it was thus difﬁcult to identify apoptotic
cells (which were rare in any case) unequivocally as GCs.
Therefore, although we were unable to demonstrate DBP-
induced GC apoptosis soon after treatment on e13.3 or
e14.5, this was primarily because of technical⁄sampling
limitations. To determine if reduced proliferation
explained the changes in GC number in DBP-exposed
animals, the PI (BrdU incorporation) was determined at
four foetal and three postnatal ages. In foetal life, GC
proliferation was >50% in controls and DBP-exposed ani-
mals at e15.5 (Fig. 2). At e17.5, most GCs (>98%) in
controls had entered quiescence and this was complete by
e19.5, whereas in DBP-exposed animals, signiﬁcantly
more GCs were still proliferating at e17.5 in comparison
with controls, although only occasional BrdU-positive
cells were evident at e19.5, and none at e21.5 (Fig. 2).
This suggested that DBP exposure delayed the entry of
some foetal GCs into quiescence.
In contrast, after birth, there was a signiﬁcant reduc-
tion in the GC PI at Pnd6 (proliferation of basally located
spermatogonia) in DBP-exposed animals compared with
controls, although this effect was not evident at either
Pnd8 or Pnd10 (Fig. 2). The reduced proliferation at
around Pnd6 will presumably have exacerbated the reduc-
tion in numbers of GCs already present from foetal life in
DBP-exposed animals, and presumably explains the
greater reduction in GC numbers evident in postnatal
compared with foetal life (Fig. 1).
Effect of DBP treatment on GC differentiation
To evaluate other aspects of GC functional differentiation,
we chose OCT4, a pluripotency-associated factor and
DMRT1, expression of which is important in mouse GC
development (Kim et al., 2007).
In controls, most GCs at e15.5 expressed OCT4, declin-
ing to 20% at e17.5 and to 0 by e19.5 (Fig. 3). In DBP-
exposed animals, signiﬁcantly more GCs (50%)
expressed OCT4 at e17.5, compared with controls, but by
e19.5, most GCs were OCT4-immunonegative (Fig. 3).
There was no difference between control and DBP-
exposed foetuses in OCT4 mRNA expression, which
declined progressively between e15.5 and e21.5 (Fig. 3).
At e17.5 in control and DBP-exposed foetuses, most
GCs were immunopositive for DMRT1 (Fig. 4). At e19.5,
Figure 1 Effect of foetal exposure to di(n-butyl) phthalate (DBP; 500 mg⁄kg⁄day), on germ-cell (GC) number at various foetal and early postnatal
ages in the rat; lower right panel shows the GC number at each age as a percentage of the respective age-matched control in relation to periods
of GC proliferative activity. Note that DBP treatment ceased 24 h before the indicated day of foetal sampling or, in the case of postnatal sam-
pling, on e21.5. Values are means ± SEM for 4–10 animals from 4 to 6 litters at each age. *p < 0.05, **p < 0.01, ***p < 0.001, in comparison
with the respective control.
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expression, which was complete by e21.5. In contrast, sig-
niﬁcantly more (>15%) GCs in DBP-exposed animals still
expressed DMRT1 at e19.5 than in controls, although
only occasional DMRT1-immunopositive GCs were still
evident by e21.5 (Fig. 4). At all ages, DMRT1 was
expressed in all Sertoli cell nuclei, and this was unaffected
by DBP treatment. After birth, all GCs remained immuno-
negative for DMRT1 at Pnd4 (not shown), but by Pnd6
most GCs in controls had switched DMRT1 back on,
based on co-expression studies with VASA (Fig. 5A,C),
whereas in DBP-exposed animals, only 60% of GCs
were positive for DMRT1 (Fig. 5B,C). Although there was
a reduced migration of GCs to the basement membrane
in DBP-exposed animals (Fig. 5D), there was no consis-
tent relationship between absence or presence of DMRT1
immunoexpression and GC position (Fig. 5B).
DBP effects on GC number and differentiation result
from effects early in gestation (e13.5–e15.5)
Restriction of DBP exposure to the period e13.5–e15.5
induced similar effects to longer period treatment on GC
number (e21.5) and prolongation of expression of OCT4
(e17.5) and DMRT1 (e19.5) (Fig. 6).
DBP exposure in early (e13.5–e15.5) or late (e19.5–
e20.5) gestation and GC aggregation at e21.5
DBP-induced GC aggregation becomes evident at e19.5–
e21.5 and was assessed at e21.5 in animals exposed in
Figure 2 Effect of foetal exposure to di(n-butyl) phthalate (DBP;
500 mg⁄kg⁄day), commencing at e13.5, on germ-cell (GC) prolifera-
tion at various foetal and early postnatal ages in the rat. Note that
DBP treatment ceased 24 h before the indicated day of foetal sam-
pling or, in the case of postnatal sampling, on e21.5. Values are
means ± SEM for 4–5 animals from four litters at each age.
*p < 0.05, in comparison with the respective control.
A B
C D
E F
H G
Figure 3 Effect of foetal exposure to di(n-butyl) phthalate (DBP;
500 mg⁄kg⁄day), commencing at e13.5, on germ-cell (GC) expression
of octamer-binding transcription factor 3⁄4 (OCT4; brown nuclear
staining) at e15.5–e19.5 in the rat. GCs are identiﬁed by their cyto-
plasmic staining for VASA (blue⁄purple colour). Note that DBP treat-
ment ceased 24 h before the indicated day of foetal sampling. Note
also that in controls, most GCs immunoexpress OCT4 at e15.5 (A),
but this decreases substantially at e17.5 (C,G) and is completely
absent at e19.5 (E). DBP exposure increases the percentage of GCs
expressing OCT4 at e17.5 (arrows; D,G), but not at e19.5 (F).
OCT4 mRNA expression (H) decreased progressively with age and was
unaffected by DBP exposure. Values in (G) and (H) are means ± SEM
for six animals from 4 to 5 litters at each age. **p < 0.01, in
comparison with the respective control.
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period e13.5–e20.5. This showed that induction of foetal
GC aggregation only needed DBP exposure in late gesta-
tion and transient exposure in an early time window
(e13.5–e15.5) was without subsequent effect (Fig. 7), in
contrast to the GC number and differentiation effects
(Fig. 6).
Discussion
These studies have characterized the effects of maternal
DBP exposure on GC development in the foetal rat testis,
with emphasis on differentiation effects and their time
course of induction. Our results show that DBP exposure
in the period immediately following testis differentiation
in the rat (e13.5) causes a major reduction in foetal GC
number and delays differentiation of some foetal GCs as
manifest by delayed switching off of OCT4 and DMRT1,
delayed entry into quiescence, delayed re-emergence from
quiescence (after birth) and delayed re-expression of
DMRT1. Induction of these effects required DBP expo-
sure only in the period immediately after testis differenti-
ation (e13.5–e15.5), which encompasses the period of
gonocyte proliferation and OCT4 expression (Culty,
2009). The 30–50% reduction in GC numbers induced by
DBP also stems from this period. In contrast, DBP expo-
sure in this early period did not induce central aggrega-
tion of GCs (this study) or of multinucleated gonocytes
(Ferrara et al., 2006); these effects only occurred after
exposure in a later time window (e19.5–e21.5) when GCs
were quiescent and had switched off OCT4 (Ferrara et al.,
2006; Culty, 2009). It is presumed that the ‘early’ and
‘late’ GC effects have separate causes.
The present ﬁndings conﬁrm and extend previous ﬁnd-
ings in vivo (Parks et al., 2000; Barlow & Foster, 2003;
Fisher et al., 2003; Ferrara et al., 2006; Boekelheide et al.,
2009) and in vitro (Chauvigne ´ et al., 2008) in the rat,
based on pregnancy exposure to DBP⁄DEHP and⁄or their
primary metabolites, and are largely consistent with
results in vivo (Gaido et al., 2007) and in vitro (Lehraiki
et al., 2009) for the mouse. Apoptosis and reduced foetal
GC number have also been shown after culturing explants
of ﬁrst trimester human foetal testes for 3 days with
10
)4 m of the DEHP metabolite monoethylhexy phthalate
(MEHP; Lambrot et al., 2009). It is therefore of interest
that the DBP-induced loss of foetal GCs in the rat occurs
similarly early (i.e. immediately after testis differentiation)
and is detectable within 24 h of initial exposure (e14.5)
to DBP; there was no cumulative effect beyond e15.5
despite continued DBP exposure. Indeed, restricting DBP
exposure to e13.5–e15.5 resulted in as big a reduction in
GC numbers at e21.5 as did continuous exposure from
e13.5 to e20.5. In vitro studies of MEHP effects on foetal
mouse testes also showed the greatest reduction in GC
numbers after early (e13.5) exposure (Lehraiki et al.,
2009). Together, these ﬁndings suggest a greater vulnera-
bility of GCs at this early stage to MEHP (or DBP). This
ﬁnding is relevant to the human, based on in vitro studies
(Lambrot et al., 2009), but it remains unknown whether
vulnerability to phthalate-induced GC apoptosis would be
restricted to the period immediately following testis
A
C
EF
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Figure 4 Effect of foetal exposure to di(n-butyl) phthalate (DBP;
500 mg⁄kg⁄day), commencing at e13.5, on expression of Doublesex
and MAB-3-related transcription factor 1 (DMRT1; brown nuclear
staining) at e17.5–e21.5 in the rat testis. Immunopositive germ cells
(GCs; asterisks) occupy a central position within the seminiferous
cords, whereas Sertoli cells, which immunoexpress DMRT1 at all ages,
are located in a ring to the periphery. Note that DBP treatment ceased
24 h before the indicated day of foetal sampling. Note also that in
controls, most GCs immunoexpress DMRT1 at e17.5 (A), but this
decreases to 7% at e19.5 (C,G) and to 0 at e21.5 (E). DBP exposure
increases the percentage of GCs expressing DMRT1 at e19.5 (D,G)
and in only occasional GCs at e21.5 (F). Values in (G) are
means ± SEM for four animals per treatment from four separate lit-
ters. *p < 0.05, in comparison with the respective control.
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immunopositive, proliferating foetal GCs are present
throughout gestation, unlike in rodents (Mitchell et al.,
2008, 2010). We were unable to show that increased
apoptosis explained the DBP-induced reduction in GC
number in rats, possibly because of the 8–24 h delay
between last DBP exposure and sample collection. How-
ever, in vitro studies using rat, mouse and human foetal
testis explants have all shown increased GC apoptosis
acutely after MEHP exposure (Chauvigne ´ et al., 2008;
Lambrot et al., 2009; Lehraiki et al., 2009), so it seems
reasonable to conclude that transiently increased apopto-
sis at around e13.5–e14.5 explains our in vivo ﬁndings,
especially as DBP clearly did not reduce GC proliferation.
In a previous observational study, we showed that foe-
tal DBP exposure transiently prolonged OCT4 immuno-
expression in male, but not in female, GCs (Ferrara et al.,
2006). We conﬁrm and quantify this effect in male rats in
the present studies and show that it is not because of
altered OCT4 mRNA expression. We also show for the
ﬁrst time that there is similar transient prolongation of
DMRT1 immunoexpression in foetal GCs in DBP-
exposed rats, although this occurred later (e19.5) than for
OCT4 (e17.5). Moreover, we show a similar delay in the
postnatal switching back on of DMRT1 immunoexpres-
sion in some GCs. In contrast, DMRT1 immunoexpres-
sion in Sertoli cells was unaltered at any age by DBP
exposure. The effects of DBP exposure on DMRT1
immunoexpression are of interest for several reasons. For
example, selective loss of GC DMRT1 in mice predisposes
to teratoma formation and DMRT1 is a suppressor of
downstream gene targets of OCT4, with similar associa-
tion evidence for human TGCC (Krentz et al., 2009;
Murphy et al., in press). The DBP-induced alteration in
DMRT1 expression is therefore of potential relevance to
the origins⁄causes of human TGCC, although the pattern
of change induced (delayed switching off and on) cannot
be related in a straightforward manner to the mouse
studies in which it was loss of DMRT1 expression that
predisposed to teratoma formation (Krentz et al., 2009).
AB
CD
Figure 5 Effect of foetal exposure to di(n-butyl) phthalate (DBP; 500 mg⁄kg⁄day; e13.5–e21.5) on expression of Doublesex and MAB-3-related
transcription factor 1 (DMRT1; brown nuclear staining) on postnatal day 6 in the rat testis. Germ cells (GCs) are identiﬁed by their cytoplasmic
staining for VASA (blue⁄purple colour) whereas Sertoli cells, which also immunoexpress DMRT1 do not express VASA. Note that in controls, nearly
all GCs immunoexpress DMRT1 (A,C), whereas in DBP-exposed animals, some GCs are negative for DMRT1 [white arrowheads in (B) and quantiﬁ-
cation in (C)]. In controls, most GCs have migrated to the basement membrane [black arrowheads in (A) and quantiﬁcation in (D)], whereas in
DBP-exposed animals, fewer GCs have completed this migration (B,D). Note that most centrally located GCs are immunopositive for DMRT1
in both controls and DBP-exposed animals (arrows). Values in (C) and (D) are means ± SEM for 4–6 animals per treatment from four litters.
*p < 0.05, ***p < 0.001, in comparison with the respective control.
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reportedly required for normal migration of GCs (differ-
entiating spermatogonia) to the basement membrane
(Fahrioglu et al., 2007; Kim et al., 2007). As DBP expo-
sure delayed the postnatal re-expression of DMRT1 in
some GCs in the rat as well as reducing the migration of
GCs to the basement membrane, the former may explain
the latter. Although we have not undertaken a rigorous
investigation of this possibility, we noted that DMRT1-
immunonegative and -immunopositive GCs were
observed in both central and basement membrane loca-
tions in Pnd6 rats following foetal DBP exposure.
Arguably, the most important ﬁnding from the present
studies is the demonstration that all of the effects of DBP
exposure on foetal GC number and differentiation were
shown to originate within e13.5–e15.5, when GCs are
actively proliferating and expressing OCT4 (Ferrara et al.,
2006). This was the case irrespective of the age at which a
particular effect of DBP exposure was ﬁrst detectable,
namely e14.5 (reduced GC number), e17.5 (OCT4 pro-
longation) or e19.5 (DMRT1 prolongation). This implies
that there are DBP-sensitive mechanisms in GCs during
this period, the future identiﬁcation of which could be
Figure 6 Identiﬁcation of an early time window (e13.5–e15.5) of
foetal exposure to di(n-butyl) phthalate (DBP; 500 mg⁄kg⁄day) for
induction of prolongation of octamer-binding transcription factor 3⁄4
and Doublesex and MAB-3-related transcription factor 1 immunoex-
pression in germ cells (GCs) and for induction of a decrease in GC
number in the rat. The duration of vehicle⁄DBP treatment is shown
on the x-axis of each graph and the age of evaluation in the heading.
Values are means ± SEM for 4–10 animals in each treatment group
from 4 to 5 litters. *p < 0.05, **p < 0.01, in comparison with the
respective control.
Figure 7 Identiﬁcation of a late time window (e19.5–e20.5) of foetal
exposure to di(n-butyl) phthalate (DBP; 500 mg⁄kg⁄day) for induction
of abnormal germ-cell (GC) aggregation at e21.5 in the rat. GCs were
identiﬁed by their cytoplasmic staining for VASA (brown colour) and
thresholding and image analysis used to compute GC clustering⁄
aggregation (see ‘Materials and methods’). Note that DBP treatment
from e13.5 to e15.5 (early window) had no effect. The control group
comprises a mixture of animals treated for each of the periods
corresponding to those for DBP and were pooled because they did
not show any signiﬁcant treatment-related differences. Values are
means ± SEM for 4–10 animals in each treatment group from 4 to
5 litters. ***p < 0.001, in comparison with the control.
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induced by MEHP in human foetal testes in vitro at an
equivalent stage of development (Lambrot et al., 2009).
These might also have relevance to the origins of CIS,
especially as they can impact factors such as OCT4 and
DMRT1 in GCs (Rajpert-De Meyts & Hoei-Hansen,
2007). Furthermore, this early time window largely pre-
dates the ontogeny of Leydig cell steroidogenesis, consis-
tent with evidence from mouse studies that divorce
MEHP effects on GCs from either androgen or oestrogen
action (Gaido et al., 2007; Lehraiki et al., 2009). In con-
trast, GC aggregation (also reported as increased seminif-
erous cord diameter), which ﬁrst manifests at e19.5–e21.5
in rats (Barlow & Foster, 2003; Kleymenova et al., 2005;
Ferrara et al., 2006), was shown to be insensitive to DBP
induction by exposure during e13.5–e15.5, but was
induced by exposure from e19.5 to e20.5. We showed that
DBP induction of multinucleated gonocytes in rats was
also restricted to this late time window (Ferrara et al.,
2006). This suggests that the ‘early’ and ‘late’ effects of
DBP operate through different mechanisms; some studies
suggest that the ‘late’ effects are related to altered Sertoli
cell function⁄interaction with the GCs (Kleymenova et al.,
2005). No studies have yet reported whether MEHP or
other phthalate metabolites can induce foetal GC aggrega-
tion or multinucleation in vitro in human foetal testes.
The present study did not explore the dose–response
relationship for the GC effects of DBP as the aim was to
characterize effects at dose levels of exposure, which
induce TDS-like effects in the male offspring. The aim
was to identify the period of greatest vulnerability of foe-
tal GC to disruption by phthalate exposure, as this period
may prove to be relevant to the human. Whether GC
effects, similar to those we describe in rats, would occur
in humans at levels of DEHP or DBP exposure reported
for the general population (Silva et al., 2004a) is
unknown. However, studies comparing levels of primary
phthalate metabolites in amniotic ﬂuid in rats after dos-
ing with various doses of DBP with those in normal
human pregnancy suggest that target organ exposure in
the human foetus may approach those resulting from
doses of DBP used to induce effects in rats (Silva et al.,
2004b; Calafat et al., 2006). Moreover, studies in rats have
shown clearly that there are dose-additive effects of phth-
alate mixtures (Howdeshell et al., 2008b) and, as humans
are exposed to such mixtures (Silva et al., 2004b; Calafat
et al., 2006), it is possible that human phthalate exposure
may be sufﬁcient to induce foetal GC effects similar to
those presently described in the rat.
In conclusion, we show that foetal DBP exposure of
the rat induces both numerical and differentiation effects
on foetal GCs, which may be relevant to the human,
including the origins of CIS⁄TGCC, either because of
when they occur (during period prior to foetal GC differ-
entiation) or because of the endpoints affected (OCT4,
DMRT1). As little is known about the regulation of GC
development during this period (Culty, 2009), identiﬁca-
tion of these mechanisms is likely to give new insights
relevant to sensitivity of foetal GCs to disrupted develop-
ment by exposure to phthalates or perhaps to other envi-
ronmental chemicals, which in turn may give new
insights relevant to the origins of CIS. It seems likely
from the present ﬁndings and those reported in vitro
using human foetal testis tissue (Lambrot et al., 2009)
that certain phthalates (e.g. DEHP, DBP) have the poten-
tial to affect adversely foetal GCs in the human testis.
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